MedPath

A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
Behavioral: Group cognitive behavioural therapy (CBT)
Other: Activity group
Registration Number
NCT06604845
Lead Sponsor
Vastra Gotaland Region
Brief Summary

Many adults with attention deficit hyperactivity disorder (ADHD) experience difficulties with inattention, planning and impulsivity that impacts work and social life negatively also after treatment with medication. There are various psychological treatments aiming to improve these symptoms, but it is not known if they work or not.

The goal of this clinical trial is to evaluate group cognitive behavioural therapy (CBT) for adults with attention deficit hyperactivity disorder (ADHD) in comparison to an active control group consisting of a discussion and activity group. Previous research suggests that group CBT works about equally well as other structured group activities. The main questions the researchers aim to answer are if group CBT work better than activity groups to:

* Improve symptoms of ADHD

* Improve general mental health and life quality

* Improve every-day functioning

The researchers also want to learn if group CBT or activity groups work better for some people with ADHD depending on individual characteristics such as

β€’ type of symptoms, age, gender or co-occurring psychiatric diagnoses.

The comparison is a manualised structured activity group given at the same number of sessions and same group size. All participants will visit our clinics at 12 occasions. They will:

* Fill in questionnaires before and after the group intervention, and online after 6 and 12 months

* Do cognitive testing before and after the intervention

Detailed Description

Despite medical treatment, many adults with ADHD experience residual symptoms that negatively affect work performance and social life. Hence, several psychological interventions targeting these symptoms have been developed, but the treatment effects are still unclear due to lack of controlled clinical trials.

In this single-blind randomised controlled clinical trial, we will evaluate the effects of group CBT based on Safren's manual "CBT for ADHD/Mastering Your Adult ADHD" (Safren SA et al, Behav Res Ther, 2005), compared to an active control group. The control intervention is a manualised activity group that contains the same non-specific therapeutic elements as the treatment but no active CBT components. For dose equivalence, activity groups will be given with the same same number and length of sessions, and the same frequency, as the treatment conditions. Since therapist experience is known to influence outcomes, the activity groups will be held by staff with equivalent training and experience to those giving the treatment groups.

Consenting patients assessed eligible for treatment will be randomly assigned to treatment or control group using a standard digital randomisation generator with an allocation of 1:1. Patients and clinicians rating outcomes will be blind to group assignment.

Pre- and post intervention, and at 6 months and 12 months follow-up, the patient's ADHD symptoms, symptoms of anxiety and depression and general functioning will be assessed by experienced clinicians and with validated self-rating scales. Treatment fidelity and expectation will be compared for the therapy and control groups and adverse events will be registered.

An exact power calculation for estimation of sample sizes cannot be performed since effect sizes are not known. Based on a previously published studies of Safren's CBT individually administered, and general consensus of what is a clinically meaningful improvement in psychological treatments for other psychiatric diagnoses, we expect that 60 patients per arm will be sufficient for detection of clinically relevant effect sizes of approximately Cohen's d 0.3-0.4. A statistician will make a blind Bayesian stop analysis (Svensson JE et al, J Cereb Blood Flow Metab, 2021) for every 20-25 patients, and based on the results we can decide to halt the study if sufficient power has been achieved earlier than after 60 patients. Full attrition analysis with intention to treat (ITT) analysis will be performed to investigate and minimize attrition bias.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
120
Inclusion Criteria

Fulfilling criteria for ADHD , motivation and practical possibility to participate in the treatment.

Exclusion Criteria

Ongoing psychosis or suicidality, severe self-injury, intellectual disability and insufficient Swedish language skills.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group cognitive behavioural therapyGroup cognitive behavioural therapy (CBT)Group CBT based on an adapted version of individual CBT for ADHD according to Safren's manual "CBT for ADHD/Mastering Your Adult ADHD".
Activity groupActivity groupThe Activity group is a structured manualised group intervention designed by clinicians and researchers at Sahlgrenska University Hosptial.
Primary Outcome Measures
NameTimeMethod
Change in Adult ADHD Self-Report Scale (ASRS)From enrollment to the follow-up 12 months after end of treatment

ASRS is a self-reported symptom questionnaire for adults with ADHD. It has 18 questions about how often the participant experiences a certain symptom, with five response choices ranging from 0 (never) to 4 (very often) points.

Change in Clinical Global Impressions-Severity (CGI-S)At enrollment and after 12 weeks at end of treatment

CGI-S is a 7-point scale where the clinician rate the severity of the patients illness at the time of assessment.

Secondary Outcome Measures
NameTimeMethod
Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM)From enrollment to the follow-up 12 months after end of treatment

CORE-OM is a self-rating questionnaire covering general psychiatric symptoms, well-being and functioning. It has 34 questions about how often the participant experiences a certain symptom, with five response choices ranging from 0 (not at all) to 4 (most or all of the time) points.

Brunnsviken Brief Quality of Life Inventory (BBQ)From enrollment to the follow-up 12 months after end of treatment

BBQ is a validated brief version of the self-rating Quality of Life Scale, with higher sensitivity to change. It consists of 12 statements and the participant indicates how much they agree with each statement in five response choices ranging from 0 (do not agree at all) to 4 (agree completely).

Colour word Interference Test (CWIT)At enrollment and after 12 weeks at end of treatment

The cognitive task CWIT from the Delis-Kaplan Executive Function System (D-KEFS) is a version of the Stoop test aiming to measure switching and inhibition.

Trail Making Test (TMT)At enrollment and after 12 weeks at end of treatment

The cognitive test TMT from the Delis-Kaplan Executive Function System (D-KEFS) is used to measure processing speed and cognitive flexibility.

Trial Locations

Locations (1)

Sahgrenska University Hospital

πŸ‡ΈπŸ‡ͺ

Gothenburg, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath